BR112016003381A8 - sistema para administrar uma formulação de cantaridina a um indivíduo; dispositivo aplicador para administrar uma formulação de cantaridina a um indivíduo; usos de uma formulação de cantaridina; kit para administrar uma formulação de cantaridina a um indivíduo; formulações; e formulação de cantaridina - Google Patents
sistema para administrar uma formulação de cantaridina a um indivíduo; dispositivo aplicador para administrar uma formulação de cantaridina a um indivíduo; usos de uma formulação de cantaridina; kit para administrar uma formulação de cantaridina a um indivíduo; formulações; e formulação de cantaridina Download PDFInfo
- Publication number
- BR112016003381A8 BR112016003381A8 BR112016003381A BR112016003381A BR112016003381A8 BR 112016003381 A8 BR112016003381 A8 BR 112016003381A8 BR 112016003381 A BR112016003381 A BR 112016003381A BR 112016003381 A BR112016003381 A BR 112016003381A BR 112016003381 A8 BR112016003381 A8 BR 112016003381A8
- Authority
- BR
- Brazil
- Prior art keywords
- formulation
- individual
- administering
- cantidine
- cantharidine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/06—Ampoules or carpules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1412—Containers with closing means, e.g. caps
- A61J1/1418—Threaded type
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M35/00—Devices for applying media, e.g. remedies, on the human body
- A61M35/003—Portable hand-held applicators having means for dispensing or spreading integral media
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/06—Ampoules or carpules
- A61J1/065—Rigid ampoules, e.g. glass ampoules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/2006—Piercing means
- A61J1/201—Piercing means having one piercing end
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
- A61J7/0015—Devices specially adapted for taking medicines
- A61J7/0053—Syringes, pipettes or oral dispensers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/42—Colour properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Fluid Mechanics (AREA)
- Physics & Mathematics (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
resumo método, sistema, kit, e dispositivo aplicador para administrar uma formulação de cantaridina a um indivíduo, método para tratar uma verruga epitelial ou uma lesão cutânea em um indivíduo, formulação e método para tratar uma enfermidade na pele de um indivíduo são fornecidos no presente documento dispositivos, sistemas, kits e métodos para tratar condições patológicas, enfermidades ou doenças da pele, tais como verrugas da pele. em alguns exemplos, um dispositivo para tratar verrugas compreende um reservatório que inclui uma formulação de cantaridina, e um dispositivo aplicador em comunicação fluida com o reservatório que administra a formulação de cantaridina a um indivíduo. 1/1
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361868525P | 2013-08-21 | 2013-08-21 | |
US61/868,525 | 2013-08-21 | ||
PCT/US2014/052184 WO2015027111A1 (en) | 2013-08-21 | 2014-08-21 | Compositions, methods and systems for the treatment of cutaneous disorders |
Publications (2)
Publication Number | Publication Date |
---|---|
BR112016003381A8 true BR112016003381A8 (pt) | 2020-02-04 |
BR112016003381B1 BR112016003381B1 (pt) | 2022-07-12 |
Family
ID=52484176
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112016003381-7A BR112016003381B1 (pt) | 2013-08-21 | 2014-08-21 | Formulação de cantaridina para uso no tratamento de doenças da pele em um indivíduo |
Country Status (11)
Country | Link |
---|---|
US (2) | US11052064B2 (pt) |
EP (1) | EP3035992B1 (pt) |
JP (3) | JP6668240B2 (pt) |
KR (3) | KR20230129619A (pt) |
CN (2) | CN105636637A (pt) |
AU (4) | AU2014308690B2 (pt) |
BR (1) | BR112016003381B1 (pt) |
CA (1) | CA2921957C (pt) |
IL (2) | IL244182B (pt) |
MX (2) | MX2016002246A (pt) |
WO (1) | WO2015027111A1 (pt) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11052064B2 (en) | 2013-08-21 | 2021-07-06 | Verrica Pharmaceuticals Inc. | Compositions, methods and systems for the treatment of cutaneous disorders |
KR102528106B1 (ko) | 2014-12-17 | 2023-05-03 | 베리카 파마슈티컬스 인크. | 칸타리딘 및 생활성 칸타리딘 유도체의 상업적으로 실행 가능한 합성 |
EP3247996A4 (en) | 2015-01-20 | 2019-01-02 | Verrica Pharmaceuticals, Inc. | Quantification and preparation of pharmaceutical grade cantharidin |
EP3265166A1 (en) * | 2015-03-06 | 2018-01-10 | Medical Brands Research B.V. | Applicator |
US20180185258A1 (en) * | 2015-06-16 | 2018-07-05 | Mayo Foundation For Medical Education And Research | Skin care compositions |
JP2018536028A (ja) * | 2015-10-30 | 2018-12-06 | ダブニー パテンツ エル.エル.シー. | 刺青の退色および除去を行うシステム、装置、および方法 |
CN111278414A (zh) | 2017-06-06 | 2020-06-12 | 维里卡制药有限公司 | 皮肤病的治疗 |
USD900312S1 (en) | 2017-06-15 | 2020-10-27 | Verrica Pharmaceuticals, Inc. | Applicator |
US20210138214A1 (en) * | 2017-06-15 | 2021-05-13 | Verrica Pharmaceuticals, Inc. | Devices and methods for the treatment of body surface disorders |
EP3703754A1 (en) * | 2017-10-31 | 2020-09-09 | Université de Bourgogne | Therapeutical compositions for use in the treatment of non- malignant conditions associated with phosphatidylinositol-3- kinase activation: overgrowth spectrum, cutaneous capillary malformations and seborrheic keratoses |
WO2019229114A1 (en) * | 2018-05-30 | 2019-12-05 | Eviderm Institute Ab | Mild composition for use in topical treatment of skin and nail disorders caused by virus and fungus |
Family Cites Families (79)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US600556A (en) * | 1898-03-15 | Pyroxylin compound | ||
AU512465B2 (en) | 1977-01-05 | 1980-10-09 | Basf Aktiengesellschaft | Manufacture of 3-halosulfonylthiophene-carboxylic acid derivatives |
US4148893A (en) * | 1977-06-13 | 1979-04-10 | The Procter & Gamble Company | Dermatological compositions |
US4298752A (en) | 1980-09-19 | 1981-11-03 | Regents Of The University Of California | Cycloadduct precursors of cantharidin and method |
US4895727A (en) * | 1985-05-03 | 1990-01-23 | Chemex Pharmaceuticals, Inc. | Pharmaceutical vehicles for exhancing penetration and retention in the skin |
JP3117502B2 (ja) * | 1991-08-27 | 2000-12-18 | 株式会社資生堂 | 皮膚外用剤 |
JPH05255367A (ja) | 1992-02-28 | 1993-10-05 | Jitsuei O | カンタリジン誘導体組成物の製造法及びそれを含む抗ウイルス剤 |
US5445462A (en) | 1993-08-03 | 1995-08-29 | Medi-Flex Hospital Products, Inc. | Liquid applicator |
US5702694A (en) * | 1993-08-17 | 1997-12-30 | Schering-Plough Healthcare Products, Inc. | Compositions for treating corns, calluses and warts |
US5590780A (en) * | 1995-06-22 | 1997-01-07 | Wheaton Holding, Inc. | Unit dose assembly |
FR2754175B1 (fr) | 1996-10-07 | 1999-07-02 | Oreal | Utilisation d'un organopolysiloxane de nature elastomerique associe a une phase organique dans un produit de demaquillage des ongles |
US6030633A (en) * | 1998-05-18 | 2000-02-29 | West Agro, Inc. | Film-forming compositions for protecting animal skin |
JPH11335303A (ja) * | 1998-05-26 | 1999-12-07 | Lion Corp | 苦味増強方法及び皮膚外用剤 |
US6066124A (en) | 1998-11-24 | 2000-05-23 | Caillouette; James C. | Control of treatment fluid application to tissue |
USD436661S1 (en) | 1999-05-20 | 2001-01-23 | Melvin P Berry | Suppository applicator |
US6337076B1 (en) * | 1999-11-17 | 2002-01-08 | Sg Licensing Corporation | Method and composition for the treatment of scars |
US20030072814A1 (en) * | 1999-12-16 | 2003-04-17 | Maibach Howard I. | Topical pharmaceutical composition for the treatment of warts |
FR2808662B1 (fr) | 2000-05-09 | 2002-12-20 | Delviel | Systeme d'application d'une composition sur un element de surface |
US6899897B2 (en) * | 2001-06-18 | 2005-05-31 | Jaleva, Inc. | Gum resin as a carrier for topical application of pharmacologically active agents |
US6547467B2 (en) | 2001-08-29 | 2003-04-15 | Closure Medical Corporation | Microapplicators, delivery systems and methods for adhesives and sealants |
US6673031B2 (en) | 2001-09-25 | 2004-01-06 | Phillip Mark | Liquid applicator |
JP2004059446A (ja) | 2002-07-25 | 2004-02-26 | Mitsui Chemicals Inc | 脂環式化合物及びその製造方法 |
US20040162533A1 (en) * | 2003-02-06 | 2004-08-19 | Alley Kenneth A. | Applicator device |
WO2004089805A2 (en) | 2003-03-31 | 2004-10-21 | Manesis Nick J | Multi-dose liquid dispensing assembly |
US20040242770A1 (en) * | 2003-04-16 | 2004-12-02 | Feldstein Mikhail M. | Covalent and non-covalent crosslinking of hydrophilic polymers and adhesive compositions prepared therewith |
US7909808B2 (en) | 2003-06-13 | 2011-03-22 | Medlogic Global Limited | Dual-ended applicator for dispensing two fluids |
US20050019418A1 (en) | 2003-07-23 | 2005-01-27 | Crutchfield Charles E. | Wart treatment |
US20070111954A1 (en) | 2003-07-23 | 2007-05-17 | Cuticeuticals, Inc. | Apparatus and method of wart treatment |
JP2005187330A (ja) * | 2003-12-24 | 2005-07-14 | Lion Corp | 歯牙貼布用製品及びゲル組成物の選定方法 |
FR2865360B1 (fr) | 2004-01-22 | 2006-05-26 | Oreal | Applicateur comportant un element d'application solidaire, lors de l'utilisation, d'un recipient contenant un produit a appliquer |
US20060110415A1 (en) * | 2004-11-22 | 2006-05-25 | Bioderm Research | Topical Delivery System for Cosmetic and Pharmaceutical Agents |
US20050111900A1 (en) | 2004-11-30 | 2005-05-26 | Francesca Fazzolari | Ampoule and method of use |
FR2885779B1 (fr) * | 2005-05-23 | 2007-08-10 | Oreal | Dispositif de conditionnement et d'application d'un produit cosmetique ou dermatologique |
US20070187437A1 (en) | 2006-02-10 | 2007-08-16 | Nordson Corporation | Dispensing tip for liquid dispensing systems and method of making the same |
US20070275045A1 (en) | 2006-02-28 | 2007-11-29 | Evans Robin D | Composition for the treatment of warts and molluscum contagiosum |
JP5132071B2 (ja) * | 2006-03-31 | 2013-01-30 | 小林製薬株式会社 | 皮膚外用剤 |
DE102006034272A1 (de) | 2006-07-18 | 2008-01-24 | Aesculap Ag & Co. Kg | Flüssigkeitsspender in der Medizin in Form einer Handhabe sowie dessen Verwendung |
CN100465176C (zh) | 2006-08-18 | 2009-03-04 | 芜湖天远科技开发有限责任公司 | 一种提取斑蝥素的方法 |
US20080146674A1 (en) * | 2006-12-15 | 2008-06-19 | Rosenberg E William | Use of gentian violet in treatment of atopic dermatitis |
US8518076B2 (en) | 2007-01-08 | 2013-08-27 | Advanced Medical Solutions (Plymouth) Limited | Surgical adhesive applicator |
AU2008207828B2 (en) | 2007-01-25 | 2013-09-19 | Hyperbranch Medical Technology, Inc. | Applicators for multiple component formulations and the like, and methods of use thereof |
CN100545164C (zh) | 2007-02-13 | 2009-09-30 | 北京世纪博康医药科技有限公司 | 斑蝥酸钠的制备工艺 |
KR101329489B1 (ko) * | 2007-04-04 | 2013-11-13 | 엘지전자 주식회사 | 냉장고용 홈바 |
CN101036774B (zh) | 2007-04-17 | 2010-12-29 | 贵州益佰制药股份有限公司 | 一种复方斑蝥口服制剂的检测方法 |
CN101108854B (zh) | 2007-07-27 | 2010-05-26 | 贵州大学 | 一种斑蝥素分离纯化方法 |
CN101108853B (zh) | 2007-07-27 | 2010-05-26 | 贵州大学 | 斑蝥素分离纯化方法 |
DE102007046600A1 (de) | 2007-09-27 | 2009-04-02 | Linhardt Metallwarenfabrik Gmbh & Co Kg | Verfahren zum Applizieren eines flüssigen, medizinischen Behandlungsmediums auf einen zu behandelden Bereich sowie Medizinprodukt |
WO2009090495A2 (en) * | 2007-12-07 | 2009-07-23 | Foamix Ltd. | Oil and liquid silicone foamable carriers and formulations |
WO2010079513A2 (en) | 2009-01-07 | 2010-07-15 | Sanjay Banerji | Painless treatment of warts, corns & callus |
US9480691B1 (en) * | 2009-01-20 | 2016-11-01 | Hill Dermaceuticals, Inc. | Topical liquid containing refined peanut oil for treating skin proliferation or inflammation disorders |
JP5396125B2 (ja) * | 2009-03-30 | 2014-01-22 | 有限会社日本健康科学研究センター | 被膜形成型製剤 |
MX2012004144A (es) * | 2009-10-08 | 2012-05-08 | Msd Consumer Care Inc | Composicion de bajo contenido de eter y aparato de administracion. |
CN101798309A (zh) | 2009-12-04 | 2010-08-11 | 南京泽朗医药科技有限公司 | 一种从斑蝥中制备斑蝥素的方法 |
US20120016320A1 (en) * | 2010-07-13 | 2012-01-19 | Lin Michael T | Method and Device for Liquid Delivery |
US20120148520A1 (en) * | 2010-12-10 | 2012-06-14 | Michael Strobel | Organic Iodine Complex Durable Barrier With Antimicrobial Preparations |
FR2972928B1 (fr) * | 2011-03-25 | 2013-11-29 | Urgo Lab | Composition contenant une cellulose, une huile vegetale et un solvant volatil, ses utilisations comme pansement |
US20120312709A1 (en) * | 2011-04-12 | 2012-12-13 | Velcera, Inc. | Device for storing and dispensing a medicament, and packaging for containing the same |
CN102146086B (zh) | 2011-04-12 | 2012-03-07 | 贵州金桥药业有限公司 | 一种斑蝥酸钠的制备方法 |
US9486829B2 (en) | 2011-06-04 | 2016-11-08 | Optmed, Inc. | Applicator |
CN102268006B (zh) | 2011-06-15 | 2013-08-14 | 北京联合大学生物化学工程学院 | 一种复合酶提取斑蝥素的方法 |
US8871801B2 (en) * | 2011-08-01 | 2014-10-28 | Jacob LEVITT | Method of treating acquired perforating dermatosis with cantharidin |
CN102336765A (zh) | 2011-10-11 | 2012-02-01 | 江苏四环生物股份有限公司 | 从斑蝥中提取斑蝥素的方法 |
CN102526146B (zh) | 2012-01-13 | 2014-02-26 | 苏州大学 | 含有人参皂苷和斑蝥素的药物组合物及其用途 |
CN202730045U (zh) | 2012-08-13 | 2013-02-13 | 遵义医学院 | 一种斑蝥素分离纯化的装置 |
CN202920809U (zh) | 2012-09-27 | 2013-05-08 | 合肥诚者成医药科技有限公司 | 一种治疗尖锐湿疣的软膏 |
US9463180B2 (en) * | 2013-03-14 | 2016-10-11 | Quadex Pharmaceuticals, Llc | Treatment of molluscum contagiosum |
US11052064B2 (en) | 2013-08-21 | 2021-07-06 | Verrica Pharmaceuticals Inc. | Compositions, methods and systems for the treatment of cutaneous disorders |
US9994584B2 (en) | 2014-10-15 | 2018-06-12 | Lixte Biotechnology, Inc. | Process of synthesizing 3-(4-methylpiperazine-1-carbonyl)-7-oxabicyclo[2.2.1] heptane-2-carboxylic acid |
KR102528106B1 (ko) | 2014-12-17 | 2023-05-03 | 베리카 파마슈티컬스 인크. | 칸타리딘 및 생활성 칸타리딘 유도체의 상업적으로 실행 가능한 합성 |
EP3247996A4 (en) | 2015-01-20 | 2019-01-02 | Verrica Pharmaceuticals, Inc. | Quantification and preparation of pharmaceutical grade cantharidin |
AU2016220043A1 (en) | 2015-02-20 | 2017-08-31 | Pedicis Research Llc | Compositions and methods for treatment of skin infections |
USD772407S1 (en) | 2015-12-22 | 2016-11-22 | Adhezion Biomedical, Llc | Liquid dispenser having a tapered tip |
USD771250S1 (en) | 2015-12-22 | 2016-11-08 | Adhezion Biomedical, Llc | Liquid dispenser with an extended tip |
WO2017132221A1 (en) | 2016-01-25 | 2017-08-03 | Porex Corporation | Multicomponent sintered porous liquid applicator nibs |
USD801830S1 (en) | 2016-05-19 | 2017-11-07 | Adhezion Biomedical, Llc | Liquid dispenser |
CN111278414A (zh) | 2017-06-06 | 2020-06-12 | 维里卡制药有限公司 | 皮肤病的治疗 |
USD900312S1 (en) | 2017-06-15 | 2020-10-27 | Verrica Pharmaceuticals, Inc. | Applicator |
CN111819182B (zh) | 2017-10-04 | 2024-01-30 | 维里卡制药有限公司 | 斑蝥素的合成 |
USD868160S1 (en) | 2018-03-26 | 2019-11-26 | Robert Lam | Multi-nib marker |
-
2014
- 2014-08-21 US US14/913,335 patent/US11052064B2/en active Active
- 2014-08-21 CN CN201480055918.4A patent/CN105636637A/zh active Pending
- 2014-08-21 KR KR1020237029597A patent/KR20230129619A/ko not_active Application Discontinuation
- 2014-08-21 AU AU2014308690A patent/AU2014308690B2/en active Active
- 2014-08-21 CA CA2921957A patent/CA2921957C/en active Active
- 2014-08-21 JP JP2016536466A patent/JP6668240B2/ja active Active
- 2014-08-21 KR KR1020227007608A patent/KR20220037523A/ko not_active IP Right Cessation
- 2014-08-21 MX MX2016002246A patent/MX2016002246A/es unknown
- 2014-08-21 CN CN202111301935.XA patent/CN114209688A/zh active Pending
- 2014-08-21 BR BR112016003381-7A patent/BR112016003381B1/pt active IP Right Grant
- 2014-08-21 EP EP14837297.2A patent/EP3035992B1/en active Active
- 2014-08-21 KR KR1020167006679A patent/KR102373297B1/ko active IP Right Grant
- 2014-08-21 WO PCT/US2014/052184 patent/WO2015027111A1/en active Application Filing
-
2016
- 2016-02-18 IL IL244182A patent/IL244182B/en active IP Right Grant
- 2016-02-19 MX MX2023007194A patent/MX2023007194A/es unknown
-
2019
- 2019-10-17 AU AU2019250220A patent/AU2019250220A1/en not_active Abandoned
- 2019-11-08 JP JP2019202832A patent/JP7127006B2/ja active Active
-
2021
- 2021-04-23 AU AU2021202518A patent/AU2021202518B2/en active Active
- 2021-05-25 IL IL283432A patent/IL283432A/en unknown
- 2021-05-27 US US17/332,687 patent/US20210386703A1/en active Pending
-
2022
- 2022-07-01 JP JP2022107091A patent/JP2022137132A/ja active Pending
-
2023
- 2023-02-16 AU AU2023200914A patent/AU2023200914A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US20160193177A1 (en) | 2016-07-07 |
JP2022137132A (ja) | 2022-09-21 |
CA2921957C (en) | 2021-10-19 |
CA2921957A1 (en) | 2015-02-26 |
KR102373297B1 (ko) | 2022-03-11 |
KR20230129619A (ko) | 2023-09-08 |
US20210386703A1 (en) | 2021-12-16 |
KR20160045086A (ko) | 2016-04-26 |
MX2023007194A (es) | 2023-06-28 |
AU2021202518B2 (en) | 2022-12-15 |
AU2014308690A1 (en) | 2016-03-10 |
BR112016003381B1 (pt) | 2022-07-12 |
JP2016528015A (ja) | 2016-09-15 |
AU2014308690B2 (en) | 2019-07-18 |
WO2015027111A1 (en) | 2015-02-26 |
MX2016002246A (es) | 2017-04-27 |
JP6668240B2 (ja) | 2020-03-18 |
JP7127006B2 (ja) | 2022-08-29 |
AU2023200914A1 (en) | 2023-03-23 |
AU2021202518A1 (en) | 2021-05-20 |
CN105636637A (zh) | 2016-06-01 |
EP3035992B1 (en) | 2024-05-15 |
US11052064B2 (en) | 2021-07-06 |
EP3035992A1 (en) | 2016-06-29 |
CN114209688A (zh) | 2022-03-22 |
IL283432A (en) | 2021-06-30 |
AU2019250220A1 (en) | 2019-11-07 |
IL244182B (en) | 2021-06-30 |
IL244182A0 (en) | 2016-04-21 |
KR20220037523A (ko) | 2022-03-24 |
JP2020036929A (ja) | 2020-03-12 |
EP3035992A4 (en) | 2017-04-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112016003381A8 (pt) | sistema para administrar uma formulação de cantaridina a um indivíduo; dispositivo aplicador para administrar uma formulação de cantaridina a um indivíduo; usos de uma formulação de cantaridina; kit para administrar uma formulação de cantaridina a um indivíduo; formulações; e formulação de cantaridina | |
CO2018004132A2 (es) | Polipéptidos del dominio extracelular de cd80 y su uso en el tratamiento del cáncer | |
CL2015003801A1 (es) | Formulaciones de anticuerpos y metodos | |
BR112016007476A2 (pt) | métodos e dispositivos médicos de conjunto de pixel | |
CL2015002567A1 (es) | Compuestos y sus usos para modular la hemoglobina | |
BR112016012713A2 (pt) | Método para tratamento de câncer em um paciente necessitado, e, método de selecionar um paciente para um método de tratamento | |
BR112015002933A2 (pt) | dispositivo implantável para uso no corpo humano e/ou animal para substituir uma válvula de um órgão. | |
CL2015002501A1 (es) | Compuestos y usos de estos para la modulación de la hemoglobina | |
BR112015025854A2 (pt) | flagelina de roseburia e modulação imunológica | |
BR112015027282A8 (pt) | formulação líquida e kit compreendendo fenfluramina, e usos da mesma no tratamento de síndrome de dravet | |
DOP2016000109A (es) | Formas sólidas de ácido {[5-(3-clorofenil) -3-hidroxipiridin-2-carbonil] amino} acético, composiciones, y usos de las mismas. | |
BR112018070140A2 (pt) | sistema de distribuição | |
UY35427A (es) | Compuestos y sus usos en la modulación de la hemoglobina | |
BR112015020804A2 (pt) | dispositivo fototerapeutico, método e uso | |
BR112015021618A2 (pt) | métodos e composições para controle de ervas daninhas | |
BR112014018421A8 (pt) | Composições antimicrobianas compreendendo dgla, 15-ohepa e/ou 15-hetre e métodos de uso das mesmas | |
BR112015011679A2 (pt) | almofada portátil | |
EA201691808A1 (ru) | Кортикостероидные композиции для местного применения | |
BR112015032818A2 (pt) | sistema para intervenção periférica com acesso radial esquerdo em sala de cirurgia direita e método para sistema de intervenção periférica com acesso radial esquerdo em sala de cirurgia direita | |
BR112015015108A2 (pt) | cateter com marcações para facilitar o alinhamento | |
BR112015023074A2 (pt) | agentes de ligação-met e uso dos mesmos | |
EA201690323A1 (ru) | Способы лечения заболеваний уха у детей | |
BR112017009810A2 (pt) | sistema de imageamento médico, dispositivo de sc, e método | |
CL2015003563A1 (es) | Marcador para trastornos de la esfingomielinasa ácida y sus usos. | |
BR112016028895A2 (pt) | composições biofotônicas termofixas e usos destas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 21/08/2014, OBSERVADAS AS CONDICOES LEGAIS |